Familial Mediterranean fever (FMF) is the most common monogenic autoinflammatory disease,
but many rheumatologists are not well acquainted with its management. The objective of …

Juvenile idiopathic arthritis is a broad term that describes a clinically heterogeneous group
of arthritides of unknown cause, which begin before 16 years of age. This term encompasses …

Juvenile idiopathic arthritis (JIA), as a chronic condition, is associated with significant
disease- and treatment-related morbidity, thus impacting children’s quality of life. In order to …

Familial Mediterranean fever (FMF) is a disease of early onset which can lead to significant
morbidity. In 2012, Single Hub and Access point for pediatric Rheumatology in Europe (…

Background To our knowledge, the characteristics and burden of childhood arthritis have
never been studied on a worldwide basis. We aimed to investigate, with a cross-sectional study…

A great deal of work is being conducted to better define the molecular phenotype of the
individual subsets of JIA and to identify potential new targets for therapeutic interventions. The …

Background The availability of methotrexate and the introduction of multiple biological agents
have revolutionized the treatment of juvenile idiopathic arthritis (JIA). Several international …

Objective To evaluate the demographic, disease activity, disability, and health‐related quality
of life (HRQOL) differences between children with juvenile idiopathic arthritis (JIA) and …

Objective To develop a composite disease activity score for systemic JIA (sJIA) and to
provide preliminary evidence of its validity. Methods The systemic Juvenile Arthritis Disease …

Objective To compare the long-term disease state, in terms of activity and damage, of children
with juvenile idiopathic arthritis (JIA) who had their disease onset in methotrexate (MTX) or …